| 23 Issues in Aging, Adherence, and Health-Behavior Change MC Bradley, CM Hughes The Oxford Handbook of Health Communication, Behavior Change, and Treatment …, 2014 | 5 | 2014 |
| A cohort study of metformin and colorectal cancer risk among patients with diabetes mellitus MC Bradley, A Ferrara, N Achacoso, SF Ehrlich, CP Quesenberry Jr, ... Cancer epidemiology, biomarkers & prevention 27 (5), 525-530, 2018 | 66 | 2018 |
| A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization–results from IQVIA™ Disease Analyzer Germany K Hedenmalm, C Quinten, X Kurz, M Bradley, H Lee, E Eworuke European Journal of Clinical Pharmacology 79 (6), 849-858, 2023 | 4 | 2023 |
| A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022 SE Vititoe, P Govil, A Baglivo, E Beebe, EM Garry, NM Gatto, T Lasky, ... Open Forum Infectious Diseases 10 (7), ofad339, 2023 | | 2023 |
| A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions CY Lu, L Hou, J Kolonoski, AB Petrone, F Zhang, C Corey, TY Huang, ... Pharmacoepidemiology and Drug Safety 32 (3), 298-311, 2023 | 1 | 2023 |
| A New Analytic Tool for Interrupted Time Series Analysis to Assess the Impact of FDA Regulatory Actions CY Lu, L Hou, J Kolonoski, A Petrone, F Zhang, C Corey, TY Huang, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 114-115, 2021 | | 2021 |
| A simulation-based bias analysis to assess the impact of unmeasured confounding when designing non-randomized database studies RJ Desai, MC Bradley, H Lee, E Eworuke, J Weberpals, R Wyss, ... American Journal of Epidemiology, kwae102, 2024 | 2 | 2024 |
| Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study) B Clyne, MC Bradley, CM Hughes, D Clear, R McDonnell, D Williams, ... BMC health services research 13, 1-12, 2013 | 85 | 2013 |
| Addressing potentially inappropriate prescribing in primary care: results from the OPTI-SCRIPT cluster randomised controlled trial B Clyne, S Smith, C Hughes, M Bradley, F Boland, T Fahey | | |
| American Journal of Epidemiology Submitted Manuscript RJ Desai, MC Bradley, H Lee, E Eworuke, J Weberpals, R Wyss, ... | | 2024 |
| An FDA quality assessment tool for evaluation of real-world evidence observational studies MC Bradley, W Hua, S Pinheiro PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 418-418, 2020 | | 2020 |
| Aspirin and Non-Steroidal Anti-inflammatory Drug Use and Risk of Pancreatic Cancer: A systematic review M Bradley, C Hughes, M Cantwell, L Murray RCT 51, 39,876, 0 | | |
| Assessing the Risk of Intentional Self-Harm in Montelukast Users: An Observational Study in the Sentinel System Using ICD-10 Coding J Apata, JG Lyons, MC Bradley, Y Ma, ME Kempner, I Kim, E Eworuke, ... AACAP's 70th Annual Meeting, 2023 | | 2023 |
| Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding J Apata, JG Lyons, MC Bradley, Y Ma, ME Kempner, I Kim, E Eworuke, ... Journal of asthma, 1-10, 2023 | | 2023 |
| Asthma maintenance medication users in the sentinel distributed database MC Bradley, E Fazio-Eynullayeva, Y Li, J Chen, S Chin, S Deluccia, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 229-229, 2020 | | 2020 |
| Barbara Clyne, BSocSC, MSocSC MC Bradley, C Hughes, T Fahey, KL Lapane Clin Geriatr Med 28, 301-322, 2012 | | 2012 |
| Categorization of COVID-19 severity to determine mortality risk EM Garry, AR Weckstein, K Quinto, MC Bradley, T Lasky, S Leonard, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 91-91, 2021 | 1 | 2021 |
| Categorization of COVID‐19 severity to determine mortality risk EM Garry, AR Weckstein, K Quinto, MC Bradley, T Lasky, A Chakravarty, ... Pharmacoepidemiology and drug safety 31 (7), 721-728, 2022 | 9 | 2022 |
| Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety SP Pinheiro, DR Rivera, DJ Graham, AN Freedman, JM Major, ... Annals of epidemiology 26 (11), 735-740, 2016 | 6 | 2016 |
| Characteristics of Febuxostat and Allopurinol Initiators and Utilization Patterns in Real-World Settings M Bradley, E Eworuke, A Cosgrove, L Hou, D Toh PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 35-36, 2019 | | 2019 |
